Analysis of the differences between Bestifan (Viliru) and traditional chemotherapy drugs in tumor treatment

Belzutifan (Belzutifan) is a new oral small molecule targeted drug that mainly interferes with tumor growth and angiogenesis by inhibiting HIF-2α (hypoxia-inducible factor-2α). Compared with traditional chemotherapy drugs, Bestivan is highly targeted, and its mechanism of action precisely targets the key molecular pathways of tumor cells without relying on broad-spectrum killing cell methods, so it causes less damage to normal tissues.

Traditional chemotherapy drugs inhibit tumor cell proliferation by interfering with the cell division cycle or damaging DNA synthesis. While killing tumor cells, this method will also have a greater impact on normal, rapidly dividing cells, with obvious side effects such as bone marrow suppression, gastrointestinal reactions, and hair loss. By targeting HIF-2α, bestifan can inhibit tumor angiogenesis and metabolic adaptation, fundamentally weakening tumor growth ability. Therefore, treatment side effects are relatively mild and patients have better tolerance.

In terms of clinical efficacy, bezutivan has shown significant efficacy against specific types of tumors, such as clear cell renal cell carcinoma associated with VHL (Von Hippel-Lindau disease), which can delay disease progression and improve patients' quality of life. However, traditional chemotherapy has limited efficacy in similar tumors and has a high recurrence rate. It requires multiple cycles and a combination of multiple drugs, which results in greater treatment burden and toxic side effects.

To sum up, the main differences between besetifan and traditional chemotherapy drugs are its mechanism of action, targeting and safety. It can achieve therapeutic effects by precisely intervening in key pathways of tumors, reducing damage to normal tissues and improving patients' quality of life. However, although traditional chemotherapy has a wide range of applications, it has obvious side effects and relatively low efficacy. In tumor treatment strategies, bezotivan provides a more precise, safe and tolerable treatment option.

Reference materials:https://www.drugs.com/